Segmentation-before-Staining Improves Structural Fidelity in Virtual IHC-to-Multiplex IF Translation

📅 2026-03-17
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
This work addresses the distortion of nuclear count, morphology, and spatial arrangement in virtual staining when translating immunohistochemistry (IHC) images to multiplex immunofluorescence (mIF), which compromises the accuracy of clinical metrics such as the Ki67 index. To mitigate this, the authors propose an unsupervised, architecture-agnostic conditional guidance strategy that leverages continuous nuclear probability maps—generated by a pretrained foundation model for nuclei segmentation—as soft priors. This approach is complemented by a variance-preserving regularizer based on local intensity statistics to maintain cellular heterogeneity and structural fidelity in synthesized images. By incorporating continuous probability maps instead of binary masks, the method avoids boundary information loss and seamlessly integrates with diverse generative architectures—including Pix2Pix, U-Net, and diffusion models—without requiring task-specific tuning or additional annotations. Experiments on two independent datasets demonstrate significant improvements in both nuclear counting accuracy and perceptual quality of generated mIF images.

Technology Category

Application Category

📝 Abstract
Multiplex immunofluorescence (mIF) enables simultaneous single-cell quantification of multiple biomarkers within intact tissue architecture, yet its high reagent cost, multi-round staining protocols, and need for specialized imaging platforms limit routine clinical adoption. Virtual staining can synthesize mIF channels from widely available brightfield immunohistochemistry (IHC), but current translators optimize pixel-level fidelity without explicitly constraining nuclear morphology. In pathology, this gap is clinically consequential: subtle distortions in nuclei count, shape, or spatial arrangement propagate directly to quantification endpoints such as the Ki67 proliferation index, where errors of a few percent can shift treatment-relevant risk categories. This work introduces a supervision-free, architecture-agnostic conditioning strategy that injects a continuous cell probability map from a pretrained nuclei segmentation foundation model as an explicit input prior, together with a variance-preserving regularization term that matches local intensity statistics to maintain cell-level heterogeneity in synthesized fluorescence channels. The soft prior retains gradient-level boundary information lost by binary thresholding, providing a richer conditioning signal without task-specific tuning. Controlled experiments across Pix2Pix with U-Net and ResNet generators, deterministic regression U-Net, and conditional diffusion on two independent datasets demonstrate consistent improvements in nuclei count fidelity and perceptual quality, as the sole modifications. Code will be made publicly available upon acceptance.
Problem

Research questions and friction points this paper is trying to address.

virtual staining
nuclear morphology
multiplex immunofluorescence
structural fidelity
IHC-to-IF translation
Innovation

Methods, ideas, or system contributions that make the work stand out.

virtual staining
nuclei segmentation prior
multiplex immunofluorescence
variance-preserving regularization
foundation model
🔎 Similar Papers
No similar papers found.
Junhyeok Lee
Junhyeok Lee
Johns Hopkins University, Center for Language and Signal Processing
Speech and Language ProcessingSpeech ProcessingSpeech SynthesisGenerative Model
H
Han Jang
Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Republic of Korea
H
Heeseong Eum
Interdisciplinary Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Republic of Korea
J
Joon Jang
Department of Biomedical Sciences, Seoul National University, Seoul, Republic of Korea
Kyu Sung Choi
Kyu Sung Choi
Assistant Professor, Department of Radiology, Seoul National University Hospital
RadiologyNeuroimageDeep LearningNeuro-Oncology